208 related articles for article (PubMed ID: 23788657)
1. Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries.
Pinilla C; Edwards BS; Appel JR; Yates-Gibbins T; Giulianotti MA; Medina-Franco JL; Young SM; Santos RG; Sklar LA; Houghten RA
Mol Pharmacol; 2013 Sep; 84(3):314-24. PubMed ID: 23788657
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.
Kirpotina LN; Khlebnikov AI; Schepetkin IA; Ye RD; Rabiet MJ; Jutila MA; Quinn MT
Mol Pharmacol; 2010 Feb; 77(2):159-70. PubMed ID: 19903830
[TBL] [Abstract][Full Text] [Related]
3. The mathematics of a successful deconvolution: a quantitative assessment of mixture-based combinatorial libraries screened against two formylpeptide receptors.
Santos RG; Appel JR; Giulianotti MA; Edwards BS; Sklar LA; Houghten RA; Pinilla C
Molecules; 2013 May; 18(6):6408-24. PubMed ID: 23722730
[TBL] [Abstract][Full Text] [Related]
4. Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes.
Young SM; Bologa CM; Fara D; Bryant BK; Strouse JJ; Arterburn JB; Ye RD; Oprea TI; Prossnitz ER; Sklar LA; Edwards BS
Cytometry A; 2009 Mar; 75(3):253-63. PubMed ID: 18785269
[TBL] [Abstract][Full Text] [Related]
5. Direct Phenotypic Screening in Mice: Identification of Individual, Novel Antinociceptive Compounds from a Library of 734,821 Pyrrolidine Bis-piperazines.
Houghten RA; Ganno ML; McLaughlin JP; Dooley CT; Eans SO; Santos RG; LaVoi T; Nefzi A; Welmaker G; Giulianotti MA; Toll L
ACS Comb Sci; 2016 Jan; 18(1):51-64. PubMed ID: 26651386
[TBL] [Abstract][Full Text] [Related]
6. Rapid scanning structure-activity relationships in combinatorial data sets: identification of activity switches.
Medina-Franco JL; Edwards BS; Pinilla C; Appel JR; Giulianotti MA; Santos RG; Yongye AB; Sklar LA; Houghten RA
J Chem Inf Model; 2013 Jun; 53(6):1475-85. PubMed ID: 23705689
[TBL] [Abstract][Full Text] [Related]
7. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
[TBL] [Abstract][Full Text] [Related]
8. Application of small molecule FPR1 antagonists in the treatment of cancers.
Ahmet DS; Basheer HA; Salem A; Lu D; Aghamohammadi A; Weyerhäuser P; Bordiga A; Almeniawi J; Rashid S; Cooper PA; Shnyder SD; Vinader V; Afarinkia K
Sci Rep; 2020 Oct; 10(1):17249. PubMed ID: 33057069
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
[TBL] [Abstract][Full Text] [Related]
10. Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists.
Edwards BS; Bologa C; Young SM; Balakin KV; Prossnitz ER; Savchuck NP; Sklar LA; Oprea TI
Mol Pharmacol; 2005 Nov; 68(5):1301-10. PubMed ID: 16118363
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists.
Maciuszek M; Ortega-Gomez A; Maas SL; Garrido-Mesa J; Ferraro B; Perretti M; Merritt A; Nicolaes GAF; Soehnlein O; Chapman TM
Eur J Med Chem; 2021 Dec; 226():113805. PubMed ID: 34536667
[TBL] [Abstract][Full Text] [Related]
12. Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.
Zhuang Y; Wang L; Guo J; Sun D; Wang Y; Liu W; Xu HE; Zhang C
Nat Commun; 2022 Feb; 13(1):1054. PubMed ID: 35217703
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Nanomolar Melanocortin-3 Receptor (MC3R)-Selective Small Molecule Pyrrolidine Bis-Cyclic Guanidine Agonist Compounds Via a High-Throughput "Unbiased" Screening Campaign.
Doering SR; Freeman K; Debevec G; Geer P; Santos RG; Lavoi TM; Giulianotti MA; Pinilla C; Appel JR; Houghten RA; Ericson MD; Haskell-Luevano C
J Med Chem; 2021 May; 64(9):5577-5592. PubMed ID: 33886285
[TBL] [Abstract][Full Text] [Related]
14. 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.
Kirpotina LN; Schepetkin IA; Khlebnikov AI; Ruban OI; Ge Y; Ye RD; Kominsky DJ; Quinn MT
Biochem Pharmacol; 2017 Oct; 142():120-132. PubMed ID: 28690139
[TBL] [Abstract][Full Text] [Related]
15. Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.
Giovannoni MP; Schepetkin IA; Cilibrizzi A; Crocetti L; Khlebnikov AI; Dahlgren C; Graziano A; Dal Piaz V; Kirpotina LN; Zerbinati S; Vergelli C; Quinn MT
Eur J Med Chem; 2013 Jun; 64():512-28. PubMed ID: 23685570
[TBL] [Abstract][Full Text] [Related]
16. Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition.
Schepetkin IA; Khlebnikov AI; Giovannoni MP; Kirpotina LN; Cilibrizzi A; Quinn MT
Curr Med Chem; 2014; 21(13):1478-504. PubMed ID: 24350845
[TBL] [Abstract][Full Text] [Related]
17. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
[TBL] [Abstract][Full Text] [Related]
18. A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand.
Strouse JJ; Young SM; Mitchell HD; Ye RD; Prossnitz ER; Sklar LA; Edwards BS
Cytometry A; 2009 Mar; 75(3):264-70. PubMed ID: 19006074
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists.
Vergelli C; Schepetkin IA; Ciciani G; Cilibrizzi A; Crocetti L; Giovannoni MP; Guerrini G; Iacovone A; Kirpotina LN; Ye RD; Quinn MT
Drug Dev Res; 2017 Feb; 78(1):49-62. PubMed ID: 27859446
[TBL] [Abstract][Full Text] [Related]
20. 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Leopoldo M; Lucente E; Lacivita E; De Giorgio P; Quinn MT
Biochem Pharmacol; 2013 Feb; 85(3):404-16. PubMed ID: 23219934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
